Mandate

Vinge advises VNV Global in relation to the groups change of domicile from Bermuda to Sweden. 

Vinge has advised VNV Global in connection with the process of changing the group’s domicile from Bermuda to Sweden (the “Redomestication”). The Redomestication is carried out by way of a scheme of arrangement under Bermuda law, whereby Swedish Depository Receipts in VNV Global Ltd. will be exchanged for shares in the Swedish group entity VNV Global AB (publ) that, following the Redomestication, will constitute the new parent company of the group. The shares of VNV Global AB (publ) will be listed on the main market of Nasdaq Stockholm.

VNV Global Ltd. is an investment company with the business concept of using experience, expertise and a widespread network to identify and invest in assets with considerable potential for value appreciation. The company has a special focus on online marketplaces and businesses with strong network effects.
 
Vinge’s team has primarily consisted of Jesper Schönbeck, Joel Wahlberg, Boris Kotur, Annika Nyberg Ekenberg, William Kåge, Linnéa Sellström, Joel Magnusson, Emil Lindwall, Eléonore Friberg, Mikaela Falkner (Capital Markets & Public M&A) and Maria Schultzberg (tax).

 

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026